Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Sachin Wani to Adenocarcinoma

This is a "connection" page, showing publications Sachin Wani has written about Adenocarcinoma.

 
Connection Strength
  
 
 
13.340
  
  1. Enke T, Pokala SK, Hensen C, Brennan C, Gallegos J, Hochheimer CJ, Muthusamy VR, Thaker AM, Kushnir V, Early D, Rastogi A, Hammad H, Edmundowicz SA, Komanduri S, Wani S. Recurrent Barrett's esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up. Dis Esophagus. 2026 Jan 09; 39(1).
    View in: PubMed
    Score: 0.562
  2. Zhou MJ, Sawas T, Leiman DA, Wani S. Clinical Utility of Biomarkers for Barrett's Esophagus: Guidelines and Future Directions. Gastroenterol Clin North Am. 2026 Mar; 55(1):21-37.
    View in: PubMed
    Score: 0.556
  3. Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P. AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus. Gastroenterology. 2025 11; 169(6):1184-1231.
    View in: PubMed
    Score: 0.555
  4. Pokala SK, Lagergren J, Wani S. Emerging Challenges of Postendoscopy Esophageal Adenocarcinoma and Postendoscopy Esophageal Neoplasia. Gastrointest Endosc Clin N Am. 2026 Jan; 36(1):119-132.
    View in: PubMed
    Score: 0.554
  5. Wani S, Santoni G, Holmberg D, Kauppila JH, Farkkila M, Shaheen NJ, Lagergren J. Neoplasia Detection Rate and Risk of Post-endoscopy Esophageal Adenocarcinoma and Neoplasia in a Population-based Cohort Study. Clin Gastroenterol Hepatol. 2026 Mar; 24(3):667-677.
    View in: PubMed
    Score: 0.545
  6. Smith ZL, Thorgerson AM, Dawson AZ, Wani S. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy. Dig Dis Sci. 2023 12; 68(12):4439-4448.
    View in: PubMed
    Score: 0.482
  7. Wani S, Holmberg D, Santoni G, Kauppila JH, Farkkila M, von Euler-Chelpin M, Shaheen NJ, Lagergren J. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study. Gastroenterology. 2023 10; 165(4):909-919.e13.
    View in: PubMed
    Score: 0.470
  8. Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 04 01; 117(4):559-587.
    View in: PubMed
    Score: 0.433
  9. Wani S, Yadlapati R, Singh S, Sawas T, Katzka DA. Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel. Gastroenterology. 2022 02; 162(2):366-372.
    View in: PubMed
    Score: 0.419
  10. Han S, Kolb JM, Hosokawa P, Friedman C, Fox C, Scott FI, Lieu CH, Vajravelu RK, McCarter M, Murphy CC, Cook MB, Gleisner A, Falk GW, Katzka DA, Wani S. The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry. Am J Gastroenterol. 2021 04; 116(4):811-815.
    View in: PubMed
    Score: 0.404
  11. Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep. 2020 Dec 04; 22(12):61.
    View in: PubMed
    Score: 0.395
  12. Wani S, Williams JL, Falk GW, Komanduri S, Muthusamy VR, Shaheen NJ. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines. Am J Gastroenterol. 2020 11; 115(11):1869-1878.
    View in: PubMed
    Score: 0.392
  13. Wani S. Advances and Opportunities in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2021 Jan; 31(1):xv-xvi.
    View in: PubMed
    Score: 0.392
  14. Wani S, Gyawali CP, Katzka DA. AGA Clinical Practice Update on Reducing Rates of Post-Endoscopy Esophageal Adenocarcinoma: Commentary. Gastroenterology. 2020 10; 159(4):1533-1537.
    View in: PubMed
    Score: 0.384
  15. Kolb JM, Wani S. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Curr Opin Gastroenterol. 2020 07; 36(4):351-358.
    View in: PubMed
    Score: 0.383
  16. Machicado JD, Obuch JC, Goodman KA, Schefter TE, Frakes J, Hoffe S, Latifi K, Simon VC, Santangelo T, Ezekwe E, Edmundowicz SA, Brauer BC, Shah RJ, Hammad HT, Wagh MS, Attwell A, Han S, Klapman J, Wani S. Endoscopic Ultrasound Placement of Preloaded Fiducial Markers Shortens Procedure Time Compared to Back-Loaded Markers. Clin Gastroenterol Hepatol. 2019 12; 17(13):2749-2758.e2.
    View in: PubMed
    Score: 0.353
  17. Rubenstein JH, Waljee AK, Dwamena B, Bergman J, Vieth M, Wani S. Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis. Clin Gastroenterol Hepatol. 2018 09; 16(9):1529-1530.
    View in: PubMed
    Score: 0.323
  18. Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1056-1060.
    View in: PubMed
    Score: 0.311
  19. Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. J Clin Gastroenterol. 2017 01; 51(1):2-11.
    View in: PubMed
    Score: 0.301
  20. Mounzer R, Das A, Yen RD, Rastogi A, Bansal A, Hosford L, Wani S. Endoscopic and surgical treatment of malignant colorectal polyps: a population-based comparative study. Gastrointest Endosc. 2015 Mar; 81(3):733-740.e2.
    View in: PubMed
    Score: 0.265
  21. Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci. 2013 Jun; 58(6):1703-9.
    View in: PubMed
    Score: 0.233
  22. Wani S, Early D, Edmundowicz S, Sharma P. Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):704-11.
    View in: PubMed
    Score: 0.217
  23. Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology. 2011 Oct; 141(4):1179-86, 1186.e1.
    View in: PubMed
    Score: 0.205
  24. Wani S. Population-based estimates of cancer and mortality in Barrett's esophagus: implications for the future. Clin Gastroenterol Hepatol. 2011 Sep; 9(9):723-4.
    View in: PubMed
    Score: 0.204
  25. Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011 Mar; 9(3):220-7; quiz e26.
    View in: PubMed
    Score: 0.197
  26. Wani S, Sayana H, Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc. 2010 Jan; 71(1):147-66.
    View in: PubMed
    Score: 0.183
  27. Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A, Rastogi A, Sayana H, Sharma P. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol. 2009 Feb; 104(2):502-13.
    View in: PubMed
    Score: 0.173
  28. Wani S, Sharma P. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):128-9.
    View in: PubMed
    Score: 0.162
  29. Holmberg D, Liljequist Aspelund A, Wani S, Ness-Jensen E, Von Euler-Chelpin M, Kauppila JH, Santoni G, Lagergren J. Survival in post-endoscopy esophageal cancer: a Nordic population-based cohort study. Endoscopy. 2026 Jun; 58(6):588-594.
    View in: PubMed
    Score: 0.141
  30. Sawas T, Benson JT, Allen A, Wang K, Wani S, Iyer PG, Katzka DA. The metabolic profile of lean patients with esophageal adenocarcinoma and Barrett's esophagus. Dis Esophagus. 2025 Nov 01; 38(6).
    View in: PubMed
    Score: 0.139
  31. Codipilly DC, Faghani S, Vogelsang D, Moassefi M, Garg N, Hagen C, Lewis J, Leggett CL, Patil P, Konda V, Al Diffalha S, Peter S, Brinkerhoff B, Wong M, Otaki F, Katzka DA, Wani S, Shaheen N, Erickson BJ, Iyer PG. Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation. Am J Gastroenterol. 2026 Apr 01; 121(4):863-870.
    View in: PubMed
    Score: 0.134
  32. Kolb JM, Davis C, Williams JL, Holub J, Shaheen N, Wani S. High Rates of Dysplasia in a Population-Based Analysis of "Incidental" Barrett's Esophagus. Clin Gastroenterol Hepatol. 2026 May; 24(5):1280-1288.e3.
    View in: PubMed
    Score: 0.133
  33. Rubenstein JH, Sawas T, Wani S, Eluri S, Singh S, Chandar AK, Perumpail RB, Inadomi JM, Thrift AP, Piscoya A, Sultan S, Singh S, Katzka D, Davitkov P. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia. Gastroenterology. 2024 06; 166(6):1020-1055.
    View in: PubMed
    Score: 0.126
  34. Wani S. Approach to patients with positive vertical margins after endoscopic resection of Barrett's neoplasia. Endoscopy. 2024 08; 56(8):569-571.
    View in: PubMed
    Score: 0.125
  35. Peabody JW, Cruz JDC, Ganesan D, Paculdo D, Critchley-Thorne RJ, Wani S, Shaheen NJ. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB. Clin Transl Gastroenterol. 2024 01 01; 15(1):e00644.
    View in: PubMed
    Score: 0.122
  36. Han S, Turkeltaub JA, Jonas D, Attwell AR, Duloy AM, Edmundowicz SA, Hammad HT, Wagh MS, Wani S, Shah RJ. The timing of recurrence after endoscopic papillectomy. Surg Endosc. 2024 02; 38(2):688-696.
    View in: PubMed
    Score: 0.121
  37. Sijben J, Rainey L, Peters Y, Fitzgerald RC, Wani S, Kolb JM, Broeders MJM, Siersema PD. Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study. BMC Cancer. 2023 Nov 14; 23(1):1111.
    View in: PubMed
    Score: 0.121
  38. Pratap A, Qualman A, Garrett H, The E, Chauhan A, Idrovo JP, Cheng L, Wani S, Meguid RA, Meng X. Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells. Anticancer Res. 2023 Aug; 43(8):3411-3418.
    View in: PubMed
    Score: 0.119
  39. Kolb JM, Chen M, Tavakkoli A, Gallegos J, O'Hara J, Tarter W, Hochheimer CJ, Golubski B, Kopplin N, Hennessey L, Kalluri A, Devireddy S, Scott FI, Falk GW, Singal AG, Vajravelu RK, Wani S. Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening. Am J Gastroenterol. 2023 04 01; 118(4):615-626.
    View in: PubMed
    Score: 0.112
  40. Muthusamy VR, Wani S, Gyawali CP, Komanduri S. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review. Clin Gastroenterol Hepatol. 2022 12; 20(12):2696-2706.e1.
    View in: PubMed
    Score: 0.110
  41. Sawas T, Majzoub AM, Haddad J, Tielleman T, Nayfeh T, Yadlapati R, Singh S, Kolb J, Vajravelu RK, Katzka DA, Wani S. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 02; 20(2):e31-e50.
    View in: PubMed
    Score: 0.101
  42. Ho F, Torphy RJ, Friedman C, Leong S, Kim S, Wani S, Schefter T, Scott CD, Mitchell JD, Weyant MJ, Meguid RA, Gleisner AL, Goodman KA, McCarter MD. Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2021 Nov; 28(12):7208-7218.
    View in: PubMed
    Score: 0.101
  43. Kolb JM, Han S, Scott FI, Murphy CC, Hosokawa P, Wani S. Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals. Gastroenterology. 2020 12; 159(6):2238-2240.e4.
    View in: PubMed
    Score: 0.097
  44. Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019 09; 90(3):335-359.e2.
    View in: PubMed
    Score: 0.090
  45. Omar M, Thaker AM, Wani S, Simon V, Ezekwe E, Boniface M, Edmundowicz S, Obuch J, Cinnor B, Brauer BC, Wood M, Early DS, Lang GD, Mullady D, Hollander T, Kushnir V, Komanduri S, Muthusamy VR. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy. Gastrointest Endosc. 2019 09; 90(3):395-403.
    View in: PubMed
    Score: 0.088
  46. Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fernández-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ. Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia. Gastrointest Endosc. 2019 02; 89(2):247-256.e4.
    View in: PubMed
    Score: 0.085
  47. Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology. 2018 06; 154(8):2068-2086.e5.
    View in: PubMed
    Score: 0.081
  48. Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Jun; 112(6):849-865.
    View in: PubMed
    Score: 0.077
  49. Mallick R, Patnaik SK, Wani S, Bansal A. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus. Dig Dis Sci. 2016 Apr; 61(4):1039-50.
    View in: PubMed
    Score: 0.070
  50. Ge PS, Hamerski CM, Watson RR, Komanduri S, Cinnor BB, Bidari K, Klapman JB, Lin CL, Shah JN, Wani S, Donahue TR, Muthusamy VR. Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy. Gastrointest Endosc. 2015 Feb; 81(2):360-6.
    View in: PubMed
    Score: 0.065
  51. Wani S, Das A, Rastogi A, Drahos J, Ricker W, Parsons R, Bansal A, Yen R, Hosford L, Jankowski M, Sharma P, Cook MB. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study. Cancer. 2015 Jan 15; 121(2):194-201.
    View in: PubMed
    Score: 0.064
  52. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):84-90.
    View in: PubMed
    Score: 0.062
  53. Tofteland N, Singh M, Gaddam S, Wani SB, Gupta N, Rastogi A, Bansal A, Kanakadandi V, McGregor DH, Ulusarac O, Cherian R, Mathur SC, Sharma P. Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists. Dis Esophagus. 2014 Sep-Oct; 27(7):623-9.
    View in: PubMed
    Score: 0.060
  54. Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology. 2013 Sep; 145(3):548-53.e1.
    View in: PubMed
    Score: 0.059
  55. Anaparthy R, Gaddam S, Kanakadandi V, Alsop BR, Gupta N, Higbee AD, Wani SB, Singh M, Rastogi A, Bansal A, Cash BD, Young PE, Lieberman DA, Falk GW, Vargo JJ, Thota P, Sampliner RE, Sharma P. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1430-6.
    View in: PubMed
    Score: 0.059
  56. Giacchino M, Bansal A, Kim RE, Singh V, Hall SB, Singh M, Rastogi A, Moloney B, Wani SB, Gaddam S, Mathur SC, Wallace MB, Kanakadandi V, Balasubramanian G, Gupta N, Sharma P. Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett's esophagus: a prospective tandem study. Gastrointest Endosc. 2013 May; 77(5):711-8.
    View in: PubMed
    Score: 0.058
  57. Wani S. Management of low-grade dysplasia in Barrett's esophagus. Curr Opin Gastroenterol. 2012 Jul; 28(4):370-6.
    View in: PubMed
    Score: 0.055
  58. Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Sharma P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc. 2012 Sep; 76(3):531-8.
    View in: PubMed
    Score: 0.055
  59. Gaddam S, Mathur SC, Singh M, Arora J, Wani SB, Gupta N, Overhiser A, Rastogi A, Singh V, Desai N, Hall SB, Bansal A, Sharma P. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2011 Nov; 106(11):1961-9.
    View in: PubMed
    Score: 0.052
  60. Singh M, Bansal A, Curvers WL, Kara MA, Wani SB, Alvarez Herrero L, Lynch CR, van Kouwen MC, Peters FT, Keighley JD, Rastogi A, Pondugula K, Kim R, Singh V, Gaddam S, Bergman JJ, Sharma P. Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study. Endoscopy. 2011 Sep; 43(9):745-51.
    View in: PubMed
    Score: 0.052
  61. Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointest Endosc. 2011 Sep; 74(3):610-624.e2.
    View in: PubMed
    Score: 0.051
  62. Pondugula K, Wani S, Sharma P. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else? Curr Gastroenterol Rep. 2007 Dec; 9(6):468-74.
    View in: PubMed
    Score: 0.040
  63. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008 Mar; 67(3):394-8.
    View in: PubMed
    Score: 0.040
  64. Sharma P, Wani S, Rastogi A. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both? Gastrointest Endosc. 2007 Sep; 66(3):469-74.
    View in: PubMed
    Score: 0.039
  65. Sharma P, Wani S. Advances in esophageal imaging: practical applications for clinicians. Rev Gastroenterol Disord. 2006; 6 Suppl 1:S12-8.
    View in: PubMed
    Score: 0.035
  66. Wani S, Sharma P. The rationale for screening and surveillance of Barrett's metaplasia. Best Pract Res Clin Gastroenterol. 2006; 20(5):829-42.
    View in: PubMed
    Score: 0.035
  67. Sawas T, Wani S, Katzka DA. Endoscopic Surveillance After Endoscopic Eradication Therapy for Barrett's Esophagus With Neoplasia: Is the Vial Half Empty or Half Full? Gastroenterology. 2024 06; 166(6):963-964.
    View in: PubMed
    Score: 0.031
  68. Han S, Tatman P, Mehrotra S, Wani S, Attwell AR, Edmundowicz SA, Brauer BC, Wagh MS, Hammad HT, Shah RJ. Combination of ERCP-Based Modalities Increases Diagnostic Yield for Biliary Strictures. Dig Dis Sci. 2021 04; 66(4):1276-1284.
    View in: PubMed
    Score: 0.024
  69. El Hajj II, Brauer BC, Wani S, Fukami N, Attwell AR, Shah RJ. Role of per-oral pancreatoscopy in the evaluation of suspected pancreatic duct neoplasia: a 13-year U.S. single-center experience. Gastrointest Endosc. 2017 Apr; 85(4):737-745.
    View in: PubMed
    Score: 0.018
  70. Bansal A, McGregor DH, Anand O, Singh M, Rao D, Cherian R, Wani SB, Rastogi A, Singh V, House J, Jones PG, Sharma P. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus. Dis Esophagus. 2014 Nov-Dec; 27(8):751-6.
    View in: PubMed
    Score: 0.015
  71. Bansal A, Lee IH, Hong X, Anand V, Mathur SC, Gaddam S, Rastogi A, Wani SB, Gupta N, Visvanathan M, Sharma P, Christenson LK. Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol. 2011 Jun; 106(6):1055-63.
    View in: PubMed
    Score: 0.013
  72. Sharma P, Wani S, Bansal A. The quest for intestinal metaplasia--is it worth the effort? Am J Gastroenterol. 2007 Jun; 102(6):1162-5.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)